This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.

Browse

Ezetrol (Ezetimibe brand name)

REDIRECT — see ezetimibe.md

Aliases (1)
Ezetimibe (international brand name)
TYPICAL DOSE
Daily
ROUTE
CYCLE
STORAGE

Overview

What is Ezetrol (Ezetimibe brand name)?

Ezetrol is the European brand name for ezetimibe, a cholesterol absorption inhibitor used for hypercholesterolemia. Active ingredient and indications are identical to Zetia in the US.

Key Benefits

Lowers LDL-C as monotherapy or as a statin add-on, reduces cardiovascular events when combined with statins (IMPROVE-IT). Well-tolerated, useful for statin-intolerant patients or those needing additional LDL lowering.

Mechanism of Action

Blocks the NPC1L1 sterol transporter on intestinal enterocytes, preventing absorption of dietary and biliary cholesterol. Liver responds by upregulating LDL receptors, increasing LDL clearance from blood.

Pharmacokinetics

·
PeakHalf-life
Approximate curve — visual aid only, not data-precise PK

What to Expect

  • Week 1
    Tolerability and dose-response.
  • Week 2-4
    Early effect window.
  • Week 4-8
    Peak benefit assessment.
  • Week 8+
    Cycle decision point.

References

See ezetimibe.md for full source list

.
View Study
Was this helpful?
Your feedback shapes what we research deeper.

How was your experience with this compound?

Anonymous · one vote per session · results below at 5+ votes.

Loading…

See something off?

Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.

Discussion — click to load
Loading…
Continue: Extended research →
Our verdict, decision matrix, deep dives, controversies, sources

Related compounds

Cross-referenced from Ezetrol (Ezetimibe brand name)